Help us end the fiscal year strong. Donate by June 30. Give Now

At this point in the pandemic, will there be a market for the Novavax vaccine?

Jun 8, 2022
The anti-COVID shot passes muster with FDA advisers. It was developed with traditional technology, which might boost trust.
Experts recommended that the FDA approve Novavax's new COVID vaccine, which was created with more traditional technology than the methods used by Pfizer and Moderna.
Carsten Koall/Getty Images